Doubts are growing about whether the world’s emergency stockpile of 300,000 Ebola vaccine doses is enough to control future epidemics. Supply of the Merck shot, which is currently being used to fight [Read more]
SIGA Technologies, Inc. today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID). This CRADA will [Read more]
The Centers for Disease Control and Prevention (CDC) intends to award a sole source firm fixed price contract to Emergent Biodefense Operations Lansing LLC. The Government intends to purchase 9 Million doses [Read more]
The Federal Bureau of Investigation (FBI) is seeking suppliers for anti-viral therapeutic Tamiflu to support is Pandemic Flu Preparedness Program stockpile. The FBI needs approximately 3,300 does of Tamiflu each year and [Read more]
The House Appropriations Subcommittee on Labor, Health and Human Services, and Education held an oversight hearing focused on the FY2019 Budget for Health and Human Services Biodefense Activities on April 18, 2018 [Read more]
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) will purchase an anthrax treatment for $25.2 million from Elusys Therapeutics Inc. of [Read more]
The etiological agent responsible for smallpox disease, Variola viridae (VARV) is responsible for the deaths of hundreds of millions of people throughout history. While smallpox disease is eradicated, repositories of VARV remain, [Read more]
Bavarian Nordic A/S this week updated investors on its progress for the first three quarters of 2017, highlighting MVA-BN IMVAMUNE® smallpox vaccine orders and progress on their development pipeline. IMVAMUNE is a [Read more]
Elusys Therapeutics, Inc. announced today that the company has delivered the first doses of ANTHIM® (obiltoxaximab) Injection, its treatment for inhalational anthrax, to the U.S. Strategic National Stockpile (SNS), the U.S. Government’s [Read more]
See what we’re reading this week at Global Biodefense on topics including curbing the threat of MERS-CoV, BARDA medical countermeasure contracts, and a look at how the 1918 pandemic revolutionized public health. [Read more]
© 2019 STEMAR MEDIA